| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 4,523,924 | $9,545,479 | $2.11 | 29 May 2025 | Indirect |
| CareDx, Inc. | Director | Common Stock | 155,265 | $2,726,453 | $17.56 | 13 Jun 2025 | Direct |
| Intellia Therapeutics, Inc. | Director | Common Stock | 207,453 | $1,939,685 | $9.35 | 05 Jan 2026 | Direct |
| Progyny, Inc. | Director | Common Stock | 22,693 | $725,041 | $31.95 | 23 May 2024 | Direct |
| CareDx, Inc. | Director | Stock Option (right to buy) | 16,048 | $84,573 | $5.27 | 14 Jun 2024 | Direct |
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 16,634 | $35,097 | $2.11 | 29 May 2025 | Direct |
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 65,351 | 29 May 2025 | Direct | ||
| Progyny, Inc. | Director | Stock Option (Right to Buy) | 25,070 | 23 May 2024 | Direct | ||
| Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 11,450 | 11 Jun 2025 | Direct | ||
| UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10,000 | 06 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 05 Jan 2026 | 1 | +$1,402,500 | 4 | Director | 07 Jan 2026, 16:05 |
| CDNA | CareDx, Inc. | 13 Jun 2025 | 1 | $0 | 4 | Director | 17 Jun 2025, 16:35 |
| NTLA | Intellia Therapeutics, Inc. | 11 Jun 2025 | 2 | $0 | 4 | Director | 13 Jun 2025, 16:23 |
| KYTX | Kyverna Therapeutics, Inc. | 29 May 2025 | 2 | $0 | 4 | Director, 10%+ Owner | 02 Jun 2025, 18:30 |
| URGN | UroGen Pharma Ltd. | 06 Aug 2024 | 1 | $0 | 4 | Director | 08 Aug 2024, 09:11 |
| CDNA | CareDx, Inc. | 14 Jun 2024 | 1 | $0 | 4/A | Director | 20 Jun 2024, 16:43 |
| CDNA | CareDx, Inc. | 14 Jun 2024 | 2 | $0 | 4 | Director | 18 Jun 2024, 16:42 |
| NTLA | Intellia Therapeutics, Inc. | 12 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 16:19 |
| PGNY | Progyny, Inc. | 23 May 2024 | 2 | $0 | 4 | Director | 28 May 2024, 21:31 |
| KYTX | Kyverna Therapeutics, Inc. | 12 Feb 2024 | 4 | $0 | 4 | Director, 10%+ Owner | 14 Feb 2024, 19:03 |
| KYTX | Kyverna Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 07 Feb 2024, 21:58 |
| URGN | UroGen Pharma Ltd. | 07 Sep 2023 | 1 | $0 | 4 | Director | 08 Sep 2023, 15:42 |
| URGN | UroGen Pharma Ltd. | 26 Jul 2023 | 1 | +$661,494 | 4 | Director | 28 Jul 2023, 18:06 |
| CDNA | CareDx, Inc. | 16 Jun 2023 | 2 | $0 | 4 | Director | 21 Jun 2023, 18:50 |
| NTLA | Intellia Therapeutics, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:26 |
| PGNY | Progyny, Inc. | 24 May 2023 | 2 | $0 | 4 | Director | 26 May 2023, 17:01 |
| CDNA | CareDx, Inc. | 06 Jan 2023 | 1 | $0 | 4 | Director | 09 Jan 2023, 16:27 |
| PGNY | Progyny, Inc. | 24 Oct 2022 | 3 | $0 | 4 | Director | 26 Oct 2022, 17:36 |
| CDNA | CareDx, Inc. | 04 Oct 2022 | 1 | $0 | 4 | Director | 04 Oct 2022, 17:40 |
| CDNA | CareDx, Inc. | 16 Jun 2022 | 2 | $0 | 4 | Director | 21 Jun 2022, 17:10 |
| NTLA | Intellia Therapeutics, Inc. | 14 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 18:22 |
| URGN | UroGen Pharma Ltd. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 15:37 |
| PGNY | Progyny, Inc. | 24 Oct 2021 | 2 | $0 | 4 | Director | 26 Oct 2021, 17:40 |
| NTLA | Intellia Therapeutics, Inc. | 23 Jun 2021 | 2 | $0 | 4 | Director | 25 Jun 2021, 17:56 |
| CDNA | CareDx, Inc. | 16 Jun 2021 | 2 | $0 | 4 | Director | 21 Jun 2021, 19:56 |
| URGN | UroGen Pharma Ltd. | 07 Jun 2021 | 1 | $0 | 4 | Director | 09 Jun 2021, 13:45 |